L3VLUP
ProSign in

SANA · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

SANAARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • SANA
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterSANAARGX
Q3 2020none listed holders, n.a.8 holders, $3.6bn
Q4 2020none listed holders, n.a.7 holders, $4.1bn
Q1 20214 holders, $398m8 holders, $4.1bn
Q2 20213 holders, $259m9 holders, $4.6bn
Q3 20214 holders, $297m8 holders, $4.5bn
Q4 20214 holders, $206m9 holders, $5.3bn
Q1 20223 holders, $106m8 holders, $5.3bn
Q2 20223 holders, $80m13 holders, $6.5bn
Q3 20223 holders, $74m14 holders, $5.3bn
Q4 20223 holders, $46m13 holders, $5.5bn
Q1 20233 holders, $38m13 holders, $5.9bn
Q2 20233 holders, $76m18 holders, $6.6bn
Q3 20233 holders, $47m21 holders, $8.7bn
Q4 20233 holders, $50m17 holders, $6.3bn
Q1 20244 holders, $171m13 holders, $6.8bn
Q2 20243 holders, $91m14 holders, $7.9bn
Q3 20243 holders, $68m13 holders, $10.7bn
Q4 20242 holders, $26m14 holders, $12.3bn
Q1 20252 holders, $26m17 holders, $11.8bn
Q2 20251 holders, $27m18 holders, $10.8bn
Q3 20251 holders, $41m16 holders, $13.8bn
Q4 20251 holders, $27m16 holders, $14.8bn
Q1 20261 holders, $19m11 holders, $12.3bn
Q2 2026none listed holders, n.a.14 holders, $15.0bn
SANA

Sana Biotechnology Inc

Holders
2
Reported value
$26m
Buyers
0
Sellers
1

Breadth -1 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
14
Reported value
$12.3bn
Buyers
8
Sellers
6

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q4 2024

Among the 15 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only SANA (1)

Baillie Gifford & Co

Only ARGX (13)

Artisan Partners LP, Citadel Advisors LLC, D. E. Shaw & Co., Fidelity (FMR LLC), Holocene Advisors LP, Janus Henderson Group Ltd, Marshall Wace LLP, Moore Capital Management LP, Point72 Asset Management LP, T. Rowe Price Associates Inc, Voloridge Investment Management LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →